Having a great time at #SRNT2022! Excited to share work with Amanda Palmer, PhD Benjamin Toll Lisa Fucito showing that cancer survivors who currently smoke experience worse symptom burden. Encouragingly, symptom burden is not related to quit motivation

Interesting study identifying eveningness and lower circadian amplitude as potential risk factors for long-term symptom burden (e.g., fatigue, depression, and sleep problems) in breast cancer survivors

Thrilled to be headed to the Cancer Prevention and Control T32 Postdoctoral Fellowship Program Wake Forest University School of Medicine this fall, where I will be studying #symptommanagement and #tobaccocessation in #cancersurvivorship 🎉🎉🎉

To the immigrant, first-gen, underprivileged all-stars out there: I know the hustle it takes to work your way up the pipeline, to compete in a system not built for you. I see your drive/exhaustion and GRIEF at how easy it is for others. Stay patient. Don't give up. We need you.

Had a great time seeing my Smoke-Free MUSC collaborators and presenting the findings from my internship paper at the MUSC Hollings Cancer Center research retreat today! The amazing biscuits and grits were just an added bonus 😉

Congratulations to 3 newly hooded Arizona PhD.s Ciara Atkinson, PhD , Dr. Caroline Doyle and Sarah N Price, PhD - with supermentor Dr Heidi A Hamann! #cos2022

Does sleep disruption promote cancer or does cancer reciprocally disrupt sleep? A new review discusses existing evidence for both hypotheses and presents a framework into the link between #sleep and #cancer. Read: bit.ly/3LtSrwl

Patterns and predictors of smoking by race and medical diagnosis during hospital admission: A latent class analysis #science #psychology #smoking #statistics doi.org/10.4148/2572-1…

Bookmarking this one in my reference manager! A very helpful meta-analysis of CBT for individuals with cancer showing a need for improvement in the realms of health behavior and social relational outcomes, and limited impact for newly diagnosed patients.

Exciting to see the potential for open-label placebo to improve especially bothersome cancer-related symptoms, either as a standalone treatment or potentially in combination with other evidence-based interventions

Enjoyed hearing diverse leadership stories, gathering tangible takeaways, and spending time with my amazing fellow postdocs Alayna and Brianna Leitzelar, PhD at the 2022 Women's Leadership Conference co-hosted by Atrium Health and Wake Forest University School of Medicine

When reviewing articles that use the word "smoker" or something similar, I suggest to the authors to use person-centered language and then write a nice note to the editor encouraging wiggle room with the word limit

Match day 2021 was a real mix of emotions for me; excitement for the future but also anticipatory sadness of leaving Arizona. I think my past uncertain self would be comforted to know that I'd meet amazing clinical scientists and caring friends on internship

📑 #OpenAccess! What’s the relationship between cancer survivors’ #tobacco use, symptom burden, and motivation to quit smoking? Read the recently published findings in ACS Journal Cancer: ow.ly/UnMp50OClZB Sarah N Price, PhD Amanda Palmer, PhD Lisa Fucito Alana Rojewski, PhD Benjamin Toll

Cancer Survivors Who Quit Smoking May Have 36% Lower Cardiovascular Risk Than Those Who Continue Smoking ascopost.com/news/june-2023… #cancer #survivorship #smoking #cardiooncology

In press! Check out our new publication focused on the overlap between #insomnia and #fearofrecurrence in #cancer — exploratory findings from our team’s pilot RCT MGH HPRIR Mongan Institute MGH Psychiatry Mass General Cancer Center